The Legend Holdings-backed digital medical platform has raised fresh capital for a series A round led by Qiming Venture Partners.
Liangyihui, a China-based digital medical platform focused on oncology and backed by conglomerate Legend Holdings, has collected more than RMB100m ($15.5m) in a series C round led by Qiming Venture Partners, DealStreetAsia reported yesterday.
The round also featured new investors DT Capital Partners, Yuanju Capital Management and Wang Jiaquan’s family office as well as existing backers Redhill Capital and Juhe Capital.
Founded in 2013, Liangyihui operates a digital platform that provides clinical information and resources for cancer patients, hospitals and…